Characterizing the Anti-HIV Activity of Papuamide A
2008

Anti-HIV Activity of Papuamide A

publication 10 minutes Evidence: moderate

Author Information

Author(s): Andjelic Cynthia D, Planelles Vicente, Barrows Louis R

Primary Institution: University of Utah

Hypothesis

Papuamide A inhibits HIV entry into host cells.

Conclusion

Papuamide A effectively inhibits HIV entry through a direct interaction with the virus, not the host cell.

Supporting Evidence

  • Papuamide A inhibits approximately 80% of viral entry at a concentration of 710 nM.
  • Papuamide A does not bind significantly to CD4 or HIV gp120.
  • Papuamide A inhibits both X4 and R5 tropic viruses.
  • Papuamide B, C, and D also inhibit HIV entry, but less potently than A.

Takeaway

Papuamide A is like a superhero that stops the HIV virus from getting into cells, helping to protect them.

Methodology

The study used virion-based fusion assays to test the ability of papuamide A to inhibit HIV entry.

Limitations

Limited availability of papuamides B-D for testing.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/md20080027

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication